Cargando…
Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action
INTRODUCTION: Methotrexate (MTX) exerts at least part of its anti-inflammatory effects through adenosine receptors (ADOR). The aims of this study were to determine the expression of all four adenosine receptor genes (ADORA(1), ADORA(2A), ADORA(2B), ADORA(3 )and ADORA(3variant)) in rheumatoid synovia...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446521/ https://www.ncbi.nlm.nih.gov/pubmed/22682496 http://dx.doi.org/10.1186/ar3871 |
_version_ | 1782243995737391104 |
---|---|
author | Stamp, Lisa K Hazlett, Jody Roberts, Rebecca L Frampton, Christopher Highton, John Hessian, Paul A |
author_facet | Stamp, Lisa K Hazlett, Jody Roberts, Rebecca L Frampton, Christopher Highton, John Hessian, Paul A |
author_sort | Stamp, Lisa K |
collection | PubMed |
description | INTRODUCTION: Methotrexate (MTX) exerts at least part of its anti-inflammatory effects through adenosine receptors (ADOR). The aims of this study were to determine the expression of all four adenosine receptor genes (ADORA(1), ADORA(2A), ADORA(2B), ADORA(3 )and ADORA(3variant)) in rheumatoid synovial tissue and any influence of MTX exposure on this expression. Furthermore, we investigated whether polymorphisms within ADORA(3 )were associated with response and/or adverse effects associated with MTX. METHODS: Adenosine receptor gene expression was undertaken using PCR in 20 rheumatoid arthritis (RA) synovial samples. A separate cohort of 225 RA patients receiving MTX was genotyped for SNPs in the ADORA(3 )receptor gene. Double immunofluorescence was used to identify cells expressing ADOR protein. RESULTS: All ADOR genes were expressed in all synovial samples. ADORA(3 )and A(3variant )were the dominant subtypes expressed irrespective of MTX therapy. Expression of ADORA(2A )and ADORA(2B )was increased in patients receiving MTX compared to those not receiving MTX. There was no association between the ADORA(3 )rs1544224 SNP and high and low disease activity or MTX-associated adverse effects. ADORA(2B )protein expression was most obvious in vascular endothelial cells whereas ADORA(3 )protein was more abundant and expressed by synovial fibroblasts. CONCLUSIONS: We have shown that adenosine receptors are expressed in RA synovium. There is differential expression of receptors such that ADORA(3 )is expressed at significantly higher levels. This evidence demonstrates the potential for MTX to exert its anti-inflammatory effects at the primary site of pathology within the joints of patients with RA. |
format | Online Article Text |
id | pubmed-3446521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34465212012-09-20 Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action Stamp, Lisa K Hazlett, Jody Roberts, Rebecca L Frampton, Christopher Highton, John Hessian, Paul A Arthritis Res Ther Research Article INTRODUCTION: Methotrexate (MTX) exerts at least part of its anti-inflammatory effects through adenosine receptors (ADOR). The aims of this study were to determine the expression of all four adenosine receptor genes (ADORA(1), ADORA(2A), ADORA(2B), ADORA(3 )and ADORA(3variant)) in rheumatoid synovial tissue and any influence of MTX exposure on this expression. Furthermore, we investigated whether polymorphisms within ADORA(3 )were associated with response and/or adverse effects associated with MTX. METHODS: Adenosine receptor gene expression was undertaken using PCR in 20 rheumatoid arthritis (RA) synovial samples. A separate cohort of 225 RA patients receiving MTX was genotyped for SNPs in the ADORA(3 )receptor gene. Double immunofluorescence was used to identify cells expressing ADOR protein. RESULTS: All ADOR genes were expressed in all synovial samples. ADORA(3 )and A(3variant )were the dominant subtypes expressed irrespective of MTX therapy. Expression of ADORA(2A )and ADORA(2B )was increased in patients receiving MTX compared to those not receiving MTX. There was no association between the ADORA(3 )rs1544224 SNP and high and low disease activity or MTX-associated adverse effects. ADORA(2B )protein expression was most obvious in vascular endothelial cells whereas ADORA(3 )protein was more abundant and expressed by synovial fibroblasts. CONCLUSIONS: We have shown that adenosine receptors are expressed in RA synovium. There is differential expression of receptors such that ADORA(3 )is expressed at significantly higher levels. This evidence demonstrates the potential for MTX to exert its anti-inflammatory effects at the primary site of pathology within the joints of patients with RA. BioMed Central 2012 2012-06-08 /pmc/articles/PMC3446521/ /pubmed/22682496 http://dx.doi.org/10.1186/ar3871 Text en Copyright ©2012 Stamp et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Stamp, Lisa K Hazlett, Jody Roberts, Rebecca L Frampton, Christopher Highton, John Hessian, Paul A Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
title | Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
title_full | Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
title_fullStr | Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
title_full_unstemmed | Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
title_short | Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
title_sort | adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446521/ https://www.ncbi.nlm.nih.gov/pubmed/22682496 http://dx.doi.org/10.1186/ar3871 |
work_keys_str_mv | AT stamplisak adenosinereceptorexpressioninrheumatoidsynoviumabasisformethotrexateaction AT hazlettjody adenosinereceptorexpressioninrheumatoidsynoviumabasisformethotrexateaction AT robertsrebeccal adenosinereceptorexpressioninrheumatoidsynoviumabasisformethotrexateaction AT framptonchristopher adenosinereceptorexpressioninrheumatoidsynoviumabasisformethotrexateaction AT hightonjohn adenosinereceptorexpressioninrheumatoidsynoviumabasisformethotrexateaction AT hessianpaula adenosinereceptorexpressioninrheumatoidsynoviumabasisformethotrexateaction |